Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts
Lisa Nocquet(La Ligue Contre le Cancer), Frédérique Souazé(Centre National de la Recherche Scientifique)
Cited by 15
Related Papers
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
|Cell Death and Disease|2022|20
Targeting of MCL-1 in breast cancer associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1